Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study
- 27 February 2006
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 37 (7) , 651-659
- https://doi.org/10.1038/sj.bmt.1705302
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Five-year results of cyclic semi-high dose neoadjuvant chemotherapy supported by autologous peripheral blood stem-cell transplantation in patients with advanced ovarian cancerInternational Journal of Clinical Oncology, 2004
- Dose-dense cisplatin/paclitaxelEuropean Journal Of Cancer, 2002
- Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year ResultsJNCI Journal of the National Cancer Institute, 2000
- Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinomaCancer, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Very high-dose chemotherapy with autologous peripheral stem cell support in advanced ovarian cancerEuropean Journal Of Cancer, 1995
- Long-term survival in ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- High-dose chemotherapy with autologous bone marrow transplantation in patients with refractory ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinomaGynecologic Oncology, 1987
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958